Segall Bryant & Hamill LLC Reduces Stake in Mettler-Toledo International Inc. (MTD)

Segall Bryant & Hamill LLC decreased its position in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 6.0% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 100,402 shares of the medical instruments supplier’s stock after selling 6,378 shares during the period. Mettler-Toledo International comprises about 1.3% of Segall Bryant & Hamill LLC’s investment portfolio, making the stock its 9th largest holding. Segall Bryant & Hamill LLC’s holdings in Mettler-Toledo International were worth $57,734,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Cubist Systematic Strategies LLC increased its holdings in shares of Mettler-Toledo International by 20.7% during the first quarter. Cubist Systematic Strategies LLC now owns 823 shares of the medical instruments supplier’s stock worth $473,000 after buying an additional 141 shares in the last quarter. Guggenheim Capital LLC increased its holdings in shares of Mettler-Toledo International by 1.8% in the first quarter. Guggenheim Capital LLC now owns 101,833 shares of the medical instruments supplier’s stock valued at $58,556,000 after purchasing an additional 1,829 shares in the last quarter. LPL Financial LLC increased its holdings in shares of Mettler-Toledo International by 6.9% in the first quarter. LPL Financial LLC now owns 2,787 shares of the medical instruments supplier’s stock valued at $1,603,000 after purchasing an additional 181 shares in the last quarter. Sensato Investors LLC increased its holdings in shares of Mettler-Toledo International by 65.6% in the first quarter. Sensato Investors LLC now owns 28,769 shares of the medical instruments supplier’s stock valued at $16,543,000 after purchasing an additional 11,400 shares in the last quarter. Finally, Natixis increased its holdings in shares of Mettler-Toledo International by 1,085.4% in the first quarter. Natixis now owns 37,542 shares of the medical instruments supplier’s stock valued at $21,588,000 after purchasing an additional 34,375 shares in the last quarter. 92.32% of the stock is owned by institutional investors.

A number of analysts recently weighed in on the stock. Zacks Investment Research raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and set a $640.00 price target for the company in a report on Wednesday, April 11th. Deutsche Bank lowered their price target on shares of Mettler-Toledo International from $630.00 to $610.00 and set a “hold” rating for the company in a report on Friday, May 4th. Bank of America lowered their price target on shares of Mettler-Toledo International from $710.00 to $640.00 and set a “buy” rating for the company in a report on Friday, May 4th. Goldman Sachs Group cut shares of Mettler-Toledo International from a “buy” rating to a “neutral” rating in a research note on Monday, April 9th. Finally, Cleveland Research cut shares of Mettler-Toledo International from a “buy” rating to a “neutral” rating in a research note on Tuesday, May 1st. Nine research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Mettler-Toledo International currently has an average rating of “Hold” and a consensus target price of $632.00.

In other news, Director Wah-Hui Chu sold 2,850 shares of Mettler-Toledo International stock in a transaction on Friday, May 18th. The shares were sold at an average price of $566.95, for a total transaction of $1,615,807.50. Following the transaction, the director now directly owns 3,528 shares of the company’s stock, valued at $2,000,199.60. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Michael Heidingsfelder sold 2,562 shares of Mettler-Toledo International stock in a transaction on Thursday, June 7th. The stock was sold at an average price of $590.00, for a total transaction of $1,511,580.00. Following the transaction, the insider now directly owns 1,840 shares in the company, valued at $1,085,600. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 18,934 shares of company stock worth $10,795,962. Insiders own 4.80% of the company’s stock.

Mettler-Toledo International traded down $0.77, reaching $592.23, during midday trading on Thursday, Marketbeat.com reports. The company’s stock had a trading volume of 712 shares, compared to its average volume of 192,851. Mettler-Toledo International Inc. has a 52 week low of $540.24 and a 52 week high of $697.26. The stock has a market cap of $15.04 billion, a PE ratio of 33.66, a PEG ratio of 2.26 and a beta of 1.19. The company has a debt-to-equity ratio of 1.75, a quick ratio of 1.02 and a current ratio of 1.46.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, May 3rd. The medical instruments supplier reported $3.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.73 by $0.01. Mettler-Toledo International had a net margin of 13.50% and a return on equity of 90.70%. The firm had revenue of $660.82 million for the quarter, compared to analysts’ expectations of $651.87 million. During the same period last year, the firm earned $3.34 earnings per share. The business’s revenue for the quarter was up 11.1% on a year-over-year basis. sell-side analysts predict that Mettler-Toledo International Inc. will post 20.25 earnings per share for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; analytical instruments for use in life science; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; and end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries.

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTD).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply